Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
Journal:
Nutrition (Burbank, Los Angeles County, Calif.)
PMID:
27189907
Abstract
OBJECTIVE: The role of adipokines in liver transplantation (LTx) recipients who have metabolic syndrome (MetS) has seldom been assessed. The aim of this study was to investigate the concentrations of adipokines, inflammatory mediators, and insulin-resistance markers in liver recipients with MetS and its components.
Authors
Keywords
Adipokines
Adiponectin
Biomarkers
C-Reactive Protein
Chemokine CCL2
Cross-Sectional Studies
Fatty Acids, Nonesterified
Female
Humans
Inflammation Mediators
Insulin Resistance
Interleukin-6
Liver Transplantation
Male
Metabolic Syndrome
Middle Aged
Postoperative Complications
Resistin
Tumor Necrosis Factor-alpha